Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Unknown 4Active not recruiting 4Terminated 2Withdrawn 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2CNS 1Breast 1

Conditions

Stomatitis 1Pancreatic Neoplasms 1Glioblastoma 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 120sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89pembrolizumab 86Leucovorin 86toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Losartan × Clear all
NCT03951142 2023-11-01

ImPRESS

Oslo University Hospital

Phase 2 Unknown
165 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT05871333 2023-07-19

Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

Ain Shams University

Phase 2 Unknown
80 enrolled
Gastrointestinal

Stomatitis, Colorectal Neoplasms

NCT05097248 2021-10-28

Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown
52 enrolled
Breast

Breast Neoplasms

NCT01821729 2020-09-25

Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

Massachusetts General Hospital

Phase 2 Unknown
50 enrolled 11 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡